Paper26760424
Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M and 5 others. Cochrane Database Syst Rev, 2016. Cited by 67 papers, by iCite.
Cite this record
ConductScience Library. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Papers, record 26760424. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26760424
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance, Neoplasm | Major topic |
| Gestational Trophoblastic Disease | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Female | |
| Humans | |
| Pregnancy |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 23235667 | Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. | https://conductscience.org/library/papers/23235667 |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7856688 | Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. | Am J Obstet Gynecol | 1995 | https://conductscience.org/library/papers/7856688 | PubMed |
| 2 | 17711444 | EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients. | Int J Gynecol Cancer | 2008 | https://conductscience.org/library/papers/17711444 | PubMed |
| 3 | 11240657 | Workshop Report: Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society. | Int J Gynecol Cancer | 2000 | https://conductscience.org/library/papers/11240657 | PubMed |
| 4 | 8035370 | Advances in the epidemiology of gestational trophoblastic disease. | J Reprod Med | 1994 | https://conductscience.org/library/papers/8035370 | PubMed |
| 5 | 2551474 | Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide. | Cancer | 1989 | https://conductscience.org/library/papers/2551474 | PubMed |
| 6 | 19269684 | Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia. | Gynecol Oncol | 2009 | https://conductscience.org/library/papers/19269684 | PubMed |
| 7 | 12065144 | FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee. | Int J Gynaecol Obstet | 2002 | https://conductscience.org/library/papers/12065144 | PubMed |
| 8 | 7705678 | Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease. | Gynecol Oncol | 1995 | https://conductscience.org/library/papers/7705678 | PubMed |
| 9 | 15283051 | EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor. | J Reprod Med | 2004 | https://conductscience.org/library/papers/15283051 | PubMed |
| 10 | 20626175 | Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7. | J Reprod Med | 2010 | https://conductscience.org/library/papers/20626175 | PubMed |
| 11 | 19370618 | Combination chemotherapy for high-risk gestational trophoblastic tumour. | Cochrane Database Syst Rev | 2009 | https://conductscience.org/library/papers/19370618 | PubMed |
| 12 | 21263100 | Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21263100 | PubMed |
| 13 | 9826467 | Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. | Gynecol Oncol | 1998 | https://conductscience.org/library/papers/9826467 | PubMed |
| 14 | 17481633 | Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen. | Int J Gynaecol Obstet | 2007 | https://conductscience.org/library/papers/17481633 | PubMed |
| 15 | 11843379 | Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. | BJOG | 2002 | https://conductscience.org/library/papers/11843379 | PubMed |
| 16 | 3802833 | Meta-analysis in clinical trials. | Control Clin Trials | 1986 | https://conductscience.org/library/papers/3802833 | PubMed |
| 17 | 12209690 | Salvage combination chemotherapy with 5-fluorouracil and actinomycin D for patients with refractory, high-risk gestational trophoblastic tumors. | Cancer | 2002 | https://conductscience.org/library/papers/12209690 | PubMed |
| 18 | 19301571 | Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China. | J Reprod Med | 2009 | https://conductscience.org/library/papers/19301571 | PubMed |
| 19 | 17977170 | Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor. | J Reprod Med | 2007 | https://conductscience.org/library/papers/17977170 | PubMed |
| 20 | 17086803 | Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. | J Reprod Med | 2006 | https://conductscience.org/library/papers/17086803 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42740940 | Anti-Trop2-Guided Liposomes Restore Methotrexate Sensitivity in Chemoresistant Gestational Trophoblastic Neoplasia. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42740940 | PubMed |
| 42539462 | Treatment outcomes of gestational choriocarcinoma before and after EMA/CO introduction in Mongolia: a 15-year retrospective cohort study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42539462 | PubMed |
| 42500174 | Impact of different EMA/CO treatment regimens in women with gestational trophoblastic neoplasia: brazilian multicenter retrospective cohort study. | Rev Bras Ginecol Obstet | 2026 | https://conductscience.org/library/papers/42500174 | PubMed |
| 42346253 | Gestational Trophoblastic Neoplasia Following Hydatidiform Mole and Non-Molar Pregnancy: Clinical and Prognostic Features from a 40-Year Cohort Study at a Reference Center in Southern Brazil. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42346253 | PubMed |
| 42118332 | Targeting the GSK-3β/mTOR axis to overcome chemoresistance in gestational choriocarcinoma: molecular mechanisms and therapeutic opportunities. | Cancer Chemother Pharmacol | 2026 | https://conductscience.org/library/papers/42118332 | PubMed |
| 42047768 | Repurposing metformin for choriocarcinoma: targeting the AMPK/mTOR pathway. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42047768 | PubMed |
| 41859474 | Recurrent Post-Abortion Gestational Trophoblastic Neoplasia Successfully Treated with TP/TE: A Case Report. | Int Med Case Rep J | 2026 | https://conductscience.org/library/papers/41859474 | PubMed |
| 41277169 | Treatment Outcome and Associated Factors Among Women With Gestational Trophoblastic Neoplasia in Northwest Ethiopia: A Multi-Center Retrospective Cohort Study. | Cancer Control | 2025 | https://conductscience.org/library/papers/41277169 | PubMed |
| 40631439 | Diagnosis and management of gestational trophoblastic disease: 2025 update. | Int J Gynaecol Obstet | 2025 | https://conductscience.org/library/papers/40631439 | PubMed |
| 40031424 | Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta-analysis with sub-group analysis of potential prognostic factors. | Clinics (Sao Paulo) | 2025 | https://conductscience.org/library/papers/40031424 | PubMed |
| 39052205 | Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy. | Curr Treat Options Oncol | 2024 | https://conductscience.org/library/papers/39052205 | PubMed |
| 39006993 | Chemo-resistant Gestational Trophoblastic Neoplasia and the Use of Immunotherapy: A Case Report and Review of Literature. | Acta Med Philipp | 2024 | https://conductscience.org/library/papers/39006993 | PubMed |
| 38803539 | Case report: Multidrug resistant gestational trophoblastic neoplasia: focus on failure of immunotherapy and success of high-dose chemotherapy. | Front Oncol | 2024 | https://conductscience.org/library/papers/38803539 | PubMed |
| 38681028 | Potential diagnostic challenges of intracerebral hemorrhage as an index presentation of metastatic choriocarcinoma: A case series. | Clin Case Rep | 2024 | https://conductscience.org/library/papers/38681028 | PubMed |
| 38074016 | Extragonadal Nongestational Choriocarcinoma With a Widespread Metastasis in a Young Female: A Case Report and Literature Analysis With a Focus on Unmet Needs. | Cureus | 2023 | https://conductscience.org/library/papers/38074016 | PubMed |
| 38023226 | The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in gestational trophoblastic neoplasia. | Front Oncol | 2023 | https://conductscience.org/library/papers/38023226 | PubMed |
| 38008872 | Review of current literature on gestational trophoblastic neoplasia. | J Egypt Natl Canc Inst | 2023 | https://conductscience.org/library/papers/38008872 | PubMed |
| 37449086 | Challenges in treatment of gestational trophoblastic neoplasia in patients with MTHFR mutation: A case report. | Gynecol Oncol Rep | 2023 | https://conductscience.org/library/papers/37449086 | PubMed |
| 37425576 | A Metastatic Invasive Mole in a Perimenopausal Woman: A Rare Case. | Cureus | 2023 | https://conductscience.org/library/papers/37425576 | PubMed |
| 36648416 | Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis. | BJOG | 2023 | https://conductscience.org/library/papers/36648416 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26760424
GET https://conductscience.org/api/papers/v1/26760424/references?page=2